FDA’s Linking Side Effects of Bone Fractures Catches the Attention to Invokana Lawsuit Plaintiffs

April 25, 2016 – – The ProductLawyers.com comments on the escalated risk of decreased bone density and bone fractures, which have been linked to use of Invokana in as little as twelve weeks. In a number of adverse event reports to the Food and Drug Administration, the fractures have taken place after just minor falls and injuries that typically would not cause them. In September 2015, after a series of reports of bone-related injuries, the U.S FDA updated the drug’s product precautions and warnings to include bone fractures.

The Food and Drug Administration released a safety communication that detailed further information regarding the risks. With treatment, broken bones can surely heal. Obviously, this is more than comforting to those that have suffered from them. Nonetheless, in some patients, because of age as well as other factors, the healing process can take longer than expected which can limit their activity. It can even make daily routines challenging to accomplish.

A study that evaluated 714 elderly patients that were using Invokana for two years time noted huge decreases in bone mineral density, precisely on the lower spine and hip areas.

Invokana is used in treatment of patients with type-2 diabetes. Recently, the drug has been linked to a number of serious medical conditions. Invokana has also been a subject of a recent Food and Drug notification that demanded Janssen Pharmaceuticals to increase its warning label notes to better reflect these potential side effects.

Banville Law attorneys work every day to make sure that anyone that has used the drug and consequently suffered from complications they attribute to it shall be able to explore his or her legal rights to the maximum. The attorneys wish to assist individuals pursue justice by offering complimentary consultations to affected parties. The Banville Law professionals sponsor TheProductLawyers.com, which is an online website that acts as a resource for any news related to the type-2 diabetes drug.

For more information about the Invokana lawsuits, or this press release, please contact TheProductLawyers.com on 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009507